A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation - PubMed (original) (raw)
A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation
U Reusch et al. EMBO J. 1999.
Abstract
Mouse cytomegalovirus (MCMV) early gene expression interferes with the major histocompatibility complex class I (MHC class I) pathway of antigen presentation. Here we identify a 48 kDa type I transmembrane glycoprotein encoded by the MCMV early gene m06, which tightly binds to properly folded beta2-microglobulin (beta2m)-associated MHC class I molecules in the endoplasmic reticulum (ER). This association is mediated by the lumenal/transmembrane part of the protein. gp48-MHC class I complexes are transported out of the ER, pass the Golgi, but instead of being expressed on the cell surface, they are redirected to the endocytic route and rapidly degraded in a Lamp-1(+) compartment. As a result, m06-expressing cells are impaired in presenting antigenic peptides to CD8(+) T cells. The cytoplasmic tail of gp48 contains two di-leucine motifs. Mutation of the membrane-proximal di-leucine motif of gp48 restored surface expression of MHC class I, while mutation of the distal one had no effect. The results establish a novel viral mechanism for downregulation of MHC class I molecules by directly binding surface-destined MHC complexes and exploiting the cellular di-leucine sorting machinery for lysosomal degradation.
Similar articles
- Function of the cargo sorting dileucine motif in a cytomegalovirus immune evasion protein.
Fink A, Mikuličić S, Blaum F, Reddehase MJ, Florin L, Lemmermann NAW. Fink A, et al. Med Microbiol Immunol. 2019 Aug;208(3-4):531-542. doi: 10.1007/s00430-019-00604-x. Epub 2019 Apr 19. Med Microbiol Immunol. 2019. PMID: 31004199 - A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.
Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, Koszinowski UH, Hill AB, Ploegh HL. Kleijnen MF, et al. EMBO J. 1997 Feb 17;16(4):685-94. doi: 10.1093/emboj/16.4.685. EMBO J. 1997. PMID: 9049298 Free PMC article. - Cytomegaloviral control of MHC class I function in the mouse.
Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, Lucin P, Koszinowski UH. Hengel H, et al. Immunol Rev. 1999 Apr;168:167-76. doi: 10.1111/j.1600-065x.1999.tb01291.x. Immunol Rev. 1999. PMID: 10399073 Review. - Cytomegalovirus encodes a positive regulator of antigen presentation.
Holtappels R, Gillert-Marien D, Thomas D, Podlech J, Deegen P, Herter S, Oehrlein-Karpi SA, Strand D, Wagner M, Reddehase MJ. Holtappels R, et al. J Virol. 2006 Aug;80(15):7613-24. doi: 10.1128/JVI.00723-06. J Virol. 2006. PMID: 16840340 Free PMC article. - Hypothesis: MHC class I, rather than just a flagpole for CD8+ T cells is also a protease in its own right.
Müllbacher A. Müllbacher A. Immunol Cell Biol. 1997 Jun;75(3):310-7. doi: 10.1038/icb.1997.47. Immunol Cell Biol. 1997. PMID: 9243298 Review.
Cited by
- The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo.
Krmpotic A, Messerle M, Crnkovic-Mertens I, Polic B, Jonjic S, Koszinowski UH. Krmpotic A, et al. J Exp Med. 1999 Nov 1;190(9):1285-96. doi: 10.1084/jem.190.9.1285. J Exp Med. 1999. PMID: 10544200 Free PMC article. - Pleiotropic mechanisms of virus survival and persistence.
Miller CS. Miller CS. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Aug;100(2 Suppl):S27-36. doi: 10.1016/j.tripleo.2005.03.017. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005. PMID: 16037790 Free PMC article. - Reverse genetics modification of cytomegalovirus antigenicity and immunogenicity by CD8 T-cell epitope deletion and insertion.
Lemmermann NA, Kropp KA, Seckert CK, Grzimek NK, Reddehase MJ. Lemmermann NA, et al. J Biomed Biotechnol. 2011;2011:812742. doi: 10.1155/2011/812742. Epub 2010 Dec 26. J Biomed Biotechnol. 2011. PMID: 21253509 Free PMC article. Review. - Human cytomegalovirus US3 modulates destruction of MHC class I molecules.
Noriega VM, Hesse J, Gardner TJ, Besold K, Plachter B, Tortorella D. Noriega VM, et al. Mol Immunol. 2012 Jun;51(2):245-53. doi: 10.1016/j.molimm.2012.03.024. Epub 2012 Apr 10. Mol Immunol. 2012. PMID: 22497807 Free PMC article.
References
- Cell. 1991 Sep 20;66(6):1145-53 - PubMed
- Curr Opin Cell Biol. 1998 Aug;10(4):499-503 - PubMed
- Cell. 1989 Jul 28;58(2):305-15 - PubMed
- Proc Natl Acad Sci U S A. 1989 Apr;86(8):2688-92 - PubMed
- Proc Natl Acad Sci U S A. 1996 Oct 15;93(21):11327-33 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous